Amyotrophic lateral sclerosis risk factors: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
{{CMG}}{{AE}}{{MMJ}}
{{CMG}}{{AE}}{{MMJ}}
==Overview==
==Overview==
Common risk factors in the development of amyotrophic lateral sclerosis include: Smoking, [[oxidative stress]], [[heavy metal]]<nowiki/>s, chemical exposure (pesticides, [[fertilizers]], [[herbicide]]s, [[insecticides]], and [[formaldehyde]]), [[Radiation]], [[Diet]] (high level of [[glutamate]] and fat can have adverse effects on ALS patients while [[Omega 3]] fatty acids, [[Vitamin E]], and [[fiber]] can have defensive impact.) and genetic causes. Among all the [[heavy metals]] that might be associated with ALS, [[lead]] exposure seems to be studied the most possibly due to the ALS-like symptoms experienced by people exposed to high concentrations of [[lead]].
Common risk factors in the development and progression of amyotrophic lateral sclerosis largely remain unknown.
 
Other common risk factors associated include: [[Age]], Smoking, [[oxidative stress]].


==Risk Factors==
==Risk Factors==

Revision as of 13:50, 14 September 2021

Amyotrophic lateral sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amyotrophic lateral sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amyotrophic lateral sclerosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amyotrophic lateral sclerosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amyotrophic lateral sclerosis risk factors

CDC on Amyotrophic lateral sclerosis risk factors

Amyotrophic lateral sclerosis risk factors in the news

Blogs on Amyotrophic lateral sclerosis risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Amyotrophic lateral sclerosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Common risk factors in the development and progression of amyotrophic lateral sclerosis largely remain unknown. Other common risk factors associated include: Age, Smoking, oxidative stress.

Risk Factors

Common Risk Factors

References

  1. Wang W, Zhang F, Li L, Tang F, Siedlak SL, Fujioka H; et al. (2015). "MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons". J Biol Chem. 290 (1): 168–82. doi:10.1074/jbc.M114.617167. PMC 4281719. PMID 25416777.
  2. Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ; et al. (2009). "Prospective study of chemical exposures and amyotrophic lateral sclerosis". J Neurol Neurosurg Psychiatry. 80 (5): 558–61. doi:10.1136/jnnp.2008.156976. PMC 2765376. PMID 19372290.
  3. Welty DF, Schielke GP, Rothstein JD (1995). "Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis". Ann Pharmacother. 29 (11): 1164–7. doi:10.1177/106002809502901118. PMID 8573965.
  4. Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP (2002). "Lead exposure and amyotrophic lateral sclerosis". Epidemiology. 13 (3): 311–9. PMID 11964933.
  5. Morozova N, Weisskopf MG, McCullough ML, Munger KL, Calle EE, Thun MJ; et al. (2008). "Diet and amyotrophic lateral sclerosis". Epidemiology. 19 (2): 324–37. doi:10.1097/EDE.0b013e3181632c5d. PMID 18300717.
  6. Veldink JH, Kalmijn S, Groeneveld GJ, Wunderink W, Koster A, de Vries JH; et al. (2007). "Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis". J Neurol Neurosurg Psychiatry. 78 (4): 367–71. doi:10.1136/jnnp.2005.083378. PMC 2077791. PMID 16648143.
  7. Deivasigamani S, Verma HK, Ueda R, Ratnaparkhi A, Ratnaparkhi GS (2014). "A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis". Biol Open. 3 (11): 1127–38. doi:10.1242/bio.201410066. PMC 4232771. PMID 25361581.

Template:WH Template:WS